The US Food and Drug Administration (FDA) has approved the first non-prescription test that identifies the respiratory viral infections Covid-19, influenza and respiratory syncytial virus (RSV).

The regulatory approval will enable individuals exhibiting Covid-19 symptoms to buy the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test without a prescription.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Users can then self-collect a nasal swab sample at home and send it to the company Labcorp for analysis. Results will be delivered through an online portal.

According to the FDA statement, the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test can detect influenza A and B, RSV and SARS-CoV-2, which is the virus that causes Covid-19.

FDA Center for Devices and Radiological Health director Jeff Shuren said: “While the FDA has now authorised many Covid-19 tests without a prescription, this is the first test authorised for flu and RSV, along with Covid-19, where an individual can self-identify their need for a test, order it, collect their sample and send it to the lab for testing, without consulting a health care professional.

“The rapid advances being made in consumer access to diagnostic tests, including the ability to collect your sample at home for flu and RSV without a prescription, brings us one step closer to tests for these viruses that could be performed entirely at home.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Users can purchase the test online or from a store.

The test can be used by individuals 14 years and older, as well as adults, although they are advised to self-collect swabs under adult supervision.

For individuals two years and older, adult assistance is required.

Recently, the FDA also granted emergency use authorisation (EUA) for Cepheid’s Xpert Xpress CoV-2 plus test.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact